Acino Holding AG - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Acino Holding AG Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Acino Holding AG Formerly known as Schweizerhall Holding, Inc. The Group's principal activity is that of a Holding Company with interests in the chemical industry. The Group's activities specializes in the development, registration, approval, manufacturing and packaging of pharmaceuticals and generics in Europe and supplier of chemical raw materials, intermediates, specialty chemicals and customized mixtures on the Swiss market. The Group operates through two divisions. Peroral segment includes medications that are administered orally. Parenteral segment includes dosages that are not administered through gastrointestinal tract. The Group operates in Switzerland, Germany, United Kingdom, Ireland, France, Rest of Europe and Rest of World.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report